Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '25200.00203.24

Profile

Edit
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
URL https://www.abbvie.com
Investor Relations URL https://investors.abbvie.com
HQ State/Province Illinois
Sector Health Care
Industry Biotechnology
Next Earnings Release Apr. 25, 2025 (est.)
Last Earnings Release Jan. 31, 2025
Next Ex-Dividend Date Apr. 15, 2025
Last Ex-Dividend Date Jan. 15, 2025

Profile

Edit
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
URL https://www.abbvie.com
Investor Relations URL https://investors.abbvie.com
HQ State/Province Illinois
Sector Health Care
Industry Biotechnology
Next Earnings Release Apr. 25, 2025 (est.)
Last Earnings Release Jan. 31, 2025
Next Ex-Dividend Date Apr. 15, 2025
Last Ex-Dividend Date Jan. 15, 2025
Quickflows